CARESTART COVID-19 ANTIGEN TEST RCHM-02071

  • CARESTART COVID-19 ANTIGEN TEST RCHM-02071
  • CARESTART COVID-19 ANTIGEN TEST RCHM-02071
SKU:
CARESTART-RCHM-02071
UPC:
RCHM-02071
MPN:
RCHM-02071
Condition:
New
Weight:
1.00 LBS
Width:
3.00 (in)
Height:
8.00 (in)
Depth:
6.00 (in)
Shipping:
Calculated at Checkout

Bulk discount rates

Below are the available bulk discount rates for each individual item when you purchase a certain amount

Buy 10 or above and pay only $200.00 each
Online Discounted Price: $250.00
(No reviews yet) Write a Review

Description

New Lower Pricing In Stock Shipping Daily!

Results are provided at 10 minutes. 20 Tests per Box.

This test is authorized for use at the Point of Care (POC) and users must have a CLIA Certificate of Waive. 

If you are a City, County, State, or Federal Organization, We have Special Government Pricing for you. Please give us a Call 1-877-945-2876. 

Quantity 

Price Per Box or Kit

*Bulk Pricing Reflected in Cart

1-9 Boxes 20 Test Kits per Box $250 ($12.50 per Test)
10+ Boxes $200 ($10 per Test)
Pallet = 640 Boxes Call for Pricing!

 

Pallet Pricing on 640 Boxes or 12,800 Tests, Please Call 1-877-945-2876 for Quote. Lowest Prices Guaranteed on Large Quantities.

(Bulk or Pallet Pricing may not be combined with any other Discounts)

CareStart Package Insert CareStart 12 Month Extension Notice for Expiration Date
AccessBio Carestart Antigen Test  Brochure FDA EUA CareStart Antigen Tests
CareStart COVID-19 Antigen Fact Sheet for Healthcare Providers Carestart COVID-19 Antigen Fact Sheet for Patients
 Carestart performance with variants study
 

 

Due to FDA Guidelines and Supply Chain Demands All Orders for this Product are NON-Cancellable and NON-Returnable.

By purchasing the CareStart Antigen Test from Wilburn Medical you agree to the following guidelines:

This test has not been FDA cleared or approved; the test has been authorized by FDA under an Emergency Use Authorization (EUA) for use by laboratories certified under the CLIA that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC) by qualified healthcare professionals, i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

View AllClose

Warranty Information

Intended Use: The CareStartCOVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens directly collected, or collected in BD universal transport media, from individuals suspected of COVID-19 by their healthcare provider within five days of symptom onset. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories; ï‚· This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and ï‚· The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
View AllClose

Additional Information

PPE Sub Category:
COVID-19 Tests
Test Sub category:
Antgen Tests
View AllClose

0 Reviews

View AllClose